Placenta Imaging Workshop 2018 report: Multiscale and multimodal approaches.
Paddy Slator, Rosalind Aughwane, Georgina Cade...
https://pubmed.ncbi.nlm.nih.gov/30396518Actively Recruiting
Led by Carilion Clinic ยท Updated on 2026-05-22
60
Participants Needed
1
Research Sites
17 weeks
Total Duration
C
Carilion Clinic
Lead Sponsor
V
Virginia Polytechnic Institute and State University
Collaborating Sponsor
Researchers are evaluating two advanced ultrasound technologies, quantitative ultrasound (QUS) and ultrafast power Doppler imaging (uPDI), to assess placental health and blood flow in pregnancies with and without fetal growth restriction (FGR). This proof-of-concept, case-control clinical trial aims to determine whether these imaging methods can distinguish healthy pregnancies from those affected by FGR, a condition where the fetus weighs below the 10th percentile for its gestational age. Secondary goals include tracking changes in these ultrasound measures over time and their association with pregnancy complications such as severe FGR, abnormal umbilical artery Doppler results, preeclampsia, preterm birth, and stillbirth. Participants diagnosed with either normal fetal growth or FGR through standard ultrasounds will receive research ultrasounds using the Verasonics Vantage 256 system every three weeks from the time of their routine growth ultrasound until delivery. Each ultrasound session includes a standard exam to confirm fetal viability and anatomical survey, followed by detailed imaging of the placenta at multiple locations using QUS and uPDI. The study ultrasound machine displays safety indicators to ensure exposure stays within guidelines. These research ultrasounds are performed in a calm clinical setting by trained sonographers, with results shared with participants and their healthcare providers. During the study, participants will undergo repeated ultrasound assessments every three weeks until delivery, with data collected on fetal growth, placental blood flow, and tissue characteristics. Researchers will analyze the number and velocity of spiral arteries detected, speed of sound through placental tissue, and other imaging measures to identify differences between healthy and FGR pregnancies. Additional outcomes include rates of abnormal umbilical artery Doppler measurements, preeclampsia, and stillbirth. Participants will also provide demographic and medical history information to help interpret imaging results, and their routine clinical care continues independently of the research.
CONDITIONS
Placental Imaging Techniques
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - From enrollment until delivery (variable)
Participants have placental ultrasounds performed using an investigational research ultrasound device every three weeks until delivery to evaluate placental health and fetal growth.
Ultrasound visits every 3 weeks until delivery
Total: 1 location
1
Carilion Clinic Maternal Fetal Medicine
Roanoke, Virginia, United States, 24013
Actively Recruiting
M
Megan D Whitham, MD
N
Nicholas Joseph, CCRC
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Paddy Slator, Rosalind Aughwane, Georgina Cade...
https://pubmed.ncbi.nlm.nih.gov/30396518E Hernandez-Andrade, E S Huntley, M F Bartal...
https://pubmed.ncbi.nlm.nih.gov/34806234Isabelle Monier, Anne Ego, Alexandra Benachi...
https://pubmed.ncbi.nlm.nih.gov/30118693Nathan R Blue, Meghan E Beddow, Mariam Savabi...
https://pubmed.ncbi.nlm.nih.gov/29630011Lijie Huang, Yadan Wang, Rui Wang...
https://pubmed.ncbi.nlm.nih.gov/37028058Farah Deeba, Manyou Ma, Mehran Pesteie...
https://pubmed.ncbi.nlm.nih.gov/30685076